Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Grant T Baldwin

Biographic Data

ID6061235
NAMEGrant T Baldwin
GIVEN NAMESGrant T
FAMILY NAMEBaldwin
SIGNATUREBALDWIN G T
AFFILIATIONSNational Center for Injury Prevention and Control
ORCID0000-0003-1028-1494
VERIFIEDYes
TOTAL WORKS11
TOTAL CITATIONS29
AUTHOR COUNT11
EDITOR COUNT0
FIRST PUBLICATION YEAR1984
LATEST PUBLICATION YEAR2024
H-INDEX3
  • Current Cannabis Use in the United States: Implications for Public Health Research

    Grant T Baldwin, Alana Vivolo-Kantor et al.•ARTICLE•American Journal of Public Health•2024•References: 13

  • CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022

    Open Access•Deborah Dowell, Kathleen R Ragan et al.•ARTICLE•MMWR. Surveillance Summaries•2022

    This guideline provides recommendations for clinicians providing pain care, including those prescribing opioids, for outpatients aged ≥18 years. It updates the CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016 (MMWR Recomm Rep 2016;65[No. RR-1]:1-49) and includes recommendations for managing acute (duration of 3 months) pain. The recommendations do not apply to pain related to sickle cell disease or cancer or to patient…

  • Cannabis sales increases during Covid-19: Findings from Alaska, Colorado, Oregon, and Washington

    Open Access•Gillian L Schauer, Julia A Dilley et al.•ARTICLE•International Journal of Drug…•2021

  • Timing of State and Territorial Covid-19 Stay-at-Home Orders and Changes in Population Movement — United States, March 1–May 31, 2020

    Open Access•Amanda Moreland, Christine Herlihy et al.•ARTICLE•MMWR. Surveillance Summaries•2020

    SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is thought to spread from person to person primarily by the respiratory route and mainly through close contact (1). Community mitigation strategies can lower the risk for disease transmission by limiting or preventing person-to-person interactions (2). U.S. states and territories began implementing various community mitigation policies in March 2020. One widely implemented str…

  • Targeting Youth to Prevent Later Substance Use Disorder: An Underutilized Response to the US Opioid Crisis

    Wilson M Compton, Christopher M Jones et al.•ARTICLE•American Journal of Public Health•2019•Cited by: 2•References: 37

    The evolving US opioid crisis is complex and requires myriad different interventions. These include reducing opioid overprescribing and curtailing the supply of illicit opioids, overdose rescue interventions, and treatment and recovery support services for those with opioid use disorders. To date, more distal primary prevention strategies that have an evidence base are underutilized. Yet, the impact of early environments on later substance use di…

  • Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017

    Open Access•Lawrence Scholl, Puja Seth et al.•ARTICLE•MMWR. Surveillance Summaries•2018

    however, analysis of final data from 2018 is necessary for confirmation. More timely and comprehensive surveillance data are essential to inform efforts to prevent and respond to opioid overdoses; intensified prevention and response measures are urgently needed to curb deaths involving prescription and illicit opioids, specifically IMF.

  • Recent Increases in Cocaine-Related Overdose Deaths and the Role of Opioids

    Christopher M Jones, Grant T Baldwin et al.•ARTICLE•American Journal of Public Health•2017•Cited by: 4•References: 8

    Objectives. To assess trends in cocaine overdose deaths and examine the role opioids play in these deaths. Methods. We used data on drug overdose deaths in the United States from 2000 to 2015 collected in the National Vital Statistics System to calculate annual rates and numbers of cocaine-related overdose deaths overall and deaths both involving and not involving opioids. We assessed statistically significant changes in trends with joinpoint reg…

  • Relationship between Nonmedical Prescription-Opioid Use and Heroin Use

    Wilson M Compton, Christopher M Jones et al.•ARTICLE•New England Journal of Medicine•2016

    A large fraction of heroin users now report that they formerly used prescription opioids nonmedically, a finding that has led to restrictions on opioid prescribing. Nevertheless, only a small fraction of prescription-opioid users move on to heroin use.

  • National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment

    Christopher M Jones, Melinda Campopiano et al.•ARTICLE•American Journal of Public Health•2015•Cited by: 19•References: 43

    Objectives. We estimated national and state trends in opioid agonist medication-assisted treatment (OA-MAT) need and capacity to identify gaps and inform policy decisions. Methods. We generated national and state rates of past-year opioid abuse or dependence, maximum potential buprenorphine treatment capacity, number of patients receiving methadone from opioid treatment programs (OTPs), and the percentage of OTPs operating at 80% capacity or more…

  • Understanding Wicked Problems: A Key to Advancing Environmental Health Promotion

    Open Access•Marshall W Kreuter, Christopher De Rosa et al.•ARTICLE•Health Education & Behavior•2004

    Complex environmental health problems—like air and water pollution, hazardous waste sites, and lead poisoning—are in reality a constellation of linked problems embedded in the fabric of the communities in which they occur. These kinds of complex problems have been characterized by some as “wicked problems” wherein stakeholders may have conflicting interpretations of the problem and the science behind it, as well as different values, goals, and li…

  • Regulation by Cost‐benefit Analysis

    Open Access•Grant Baldwin, Grant T Baldwin et al.•ARTICLE•Public Administration•1984•Cited by: 4•References: 2

    Executive Order 12291 requires that all US federal executive agency regulations should pass a cost‐benefit test before promulgation. The Reagan Administration's procedures for implementing the Order are described and the strengths and problems of using cost‐benefit analysis to restrain and reform regulation are examined. The article then goes on to examine the feasibility of introducing a similar cost‐benefit approach in Britain. It is concluded …

  • National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment

    Christopher M Jones, Melinda Campopiano et al.•ARTICLE•American Journal of Public Health•2015•Cited by: 19•References: 43

    Objectives. We estimated national and state trends in opioid agonist medication-assisted treatment (OA-MAT) need and capacity to identify gaps and inform policy decisions. Methods. We generated national and state rates of past-year opioid abuse or dependence, maximum potential buprenorphine treatment capacity, number of patients receiving methadone from opioid treatment programs (OTPs), and the percentage of OTPs operating at 80% capacity or more…

  • Recent Increases in Cocaine-Related Overdose Deaths and the Role of Opioids

    Christopher M Jones, Grant T Baldwin et al.•ARTICLE•American Journal of Public Health•2017•Cited by: 4•References: 8

    Objectives. To assess trends in cocaine overdose deaths and examine the role opioids play in these deaths. Methods. We used data on drug overdose deaths in the United States from 2000 to 2015 collected in the National Vital Statistics System to calculate annual rates and numbers of cocaine-related overdose deaths overall and deaths both involving and not involving opioids. We assessed statistically significant changes in trends with joinpoint reg…

  • Regulation by Cost‐benefit Analysis

    Open Access•Grant Baldwin, Grant T Baldwin et al.•ARTICLE•Public Administration•1984•Cited by: 4•References: 2

    Executive Order 12291 requires that all US federal executive agency regulations should pass a cost‐benefit test before promulgation. The Reagan Administration's procedures for implementing the Order are described and the strengths and problems of using cost‐benefit analysis to restrain and reform regulation are examined. The article then goes on to examine the feasibility of introducing a similar cost‐benefit approach in Britain. It is concluded …

  • Targeting Youth to Prevent Later Substance Use Disorder: An Underutilized Response to the US Opioid Crisis

    Wilson M Compton, Christopher M Jones et al.•ARTICLE•American Journal of Public Health•2019•Cited by: 2•References: 37

    The evolving US opioid crisis is complex and requires myriad different interventions. These include reducing opioid overprescribing and curtailing the supply of illicit opioids, overdose rescue interventions, and treatment and recovery support services for those with opioid use disorders. To date, more distal primary prevention strategies that have an evidence base are underutilized. Yet, the impact of early environments on later substance use di…

  • Regulation by Cost‐benefit Analysis

    Open Access•Grant Baldwin, Grant T Baldwin et al.•ARTICLE•Public Administration•1984•Cited by: 4•References: 2

    Executive Order 12291 requires that all US federal executive agency regulations should pass a cost‐benefit test before promulgation. The Reagan Administration's procedures for implementing the Order are described and the strengths and problems of using cost‐benefit analysis to restrain and reform regulation are examined. The article then goes on to examine the feasibility of introducing a similar cost‐benefit approach in Britain. It is concluded …

  • Understanding Wicked Problems: A Key to Advancing Environmental Health Promotion

    Open Access•Marshall W Kreuter, Christopher De Rosa et al.•ARTICLE•Health Education & Behavior•2004

    Complex environmental health problems—like air and water pollution, hazardous waste sites, and lead poisoning—are in reality a constellation of linked problems embedded in the fabric of the communities in which they occur. These kinds of complex problems have been characterized by some as “wicked problems” wherein stakeholders may have conflicting interpretations of the problem and the science behind it, as well as different values, goals, and li…

  • National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment

    Christopher M Jones, Melinda Campopiano et al.•ARTICLE•American Journal of Public Health•2015•Cited by: 19•References: 43

    Objectives. We estimated national and state trends in opioid agonist medication-assisted treatment (OA-MAT) need and capacity to identify gaps and inform policy decisions. Methods. We generated national and state rates of past-year opioid abuse or dependence, maximum potential buprenorphine treatment capacity, number of patients receiving methadone from opioid treatment programs (OTPs), and the percentage of OTPs operating at 80% capacity or more…

  • Relationship between Nonmedical Prescription-Opioid Use and Heroin Use

    Wilson M Compton, Christopher M Jones et al.•ARTICLE•New England Journal of Medicine•2016

    A large fraction of heroin users now report that they formerly used prescription opioids nonmedically, a finding that has led to restrictions on opioid prescribing. Nevertheless, only a small fraction of prescription-opioid users move on to heroin use.

  • Recent Increases in Cocaine-Related Overdose Deaths and the Role of Opioids

    Christopher M Jones, Grant T Baldwin et al.•ARTICLE•American Journal of Public Health•2017•Cited by: 4•References: 8

    Objectives. To assess trends in cocaine overdose deaths and examine the role opioids play in these deaths. Methods. We used data on drug overdose deaths in the United States from 2000 to 2015 collected in the National Vital Statistics System to calculate annual rates and numbers of cocaine-related overdose deaths overall and deaths both involving and not involving opioids. We assessed statistically significant changes in trends with joinpoint reg…

  • Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017

    Open Access•Lawrence Scholl, Puja Seth et al.•ARTICLE•MMWR. Surveillance Summaries•2018

    however, analysis of final data from 2018 is necessary for confirmation. More timely and comprehensive surveillance data are essential to inform efforts to prevent and respond to opioid overdoses; intensified prevention and response measures are urgently needed to curb deaths involving prescription and illicit opioids, specifically IMF.

  • Targeting Youth to Prevent Later Substance Use Disorder: An Underutilized Response to the US Opioid Crisis

    Wilson M Compton, Christopher M Jones et al.•ARTICLE•American Journal of Public Health•2019•Cited by: 2•References: 37

    The evolving US opioid crisis is complex and requires myriad different interventions. These include reducing opioid overprescribing and curtailing the supply of illicit opioids, overdose rescue interventions, and treatment and recovery support services for those with opioid use disorders. To date, more distal primary prevention strategies that have an evidence base are underutilized. Yet, the impact of early environments on later substance use di…

  • Timing of State and Territorial Covid-19 Stay-at-Home Orders and Changes in Population Movement — United States, March 1–May 31, 2020

    Open Access•Amanda Moreland, Christine Herlihy et al.•ARTICLE•MMWR. Surveillance Summaries•2020

    SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is thought to spread from person to person primarily by the respiratory route and mainly through close contact (1). Community mitigation strategies can lower the risk for disease transmission by limiting or preventing person-to-person interactions (2). U.S. states and territories began implementing various community mitigation policies in March 2020. One widely implemented str…

  • Cannabis sales increases during Covid-19: Findings from Alaska, Colorado, Oregon, and Washington

    Open Access•Gillian L Schauer, Julia A Dilley et al.•ARTICLE•International Journal of Drug…•2021

  • CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022

    Open Access•Deborah Dowell, Kathleen R Ragan et al.•ARTICLE•MMWR. Surveillance Summaries•2022

    This guideline provides recommendations for clinicians providing pain care, including those prescribing opioids, for outpatients aged ≥18 years. It updates the CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016 (MMWR Recomm Rep 2016;65[No. RR-1]:1-49) and includes recommendations for managing acute (duration of 3 months) pain. The recommendations do not apply to pain related to sickle cell disease or cancer or to patient…

  • Current Cannabis Use in the United States: Implications for Public Health Research

    Grant T Baldwin, Alana Vivolo-Kantor et al.•ARTICLE•American Journal of Public Health•2024•References: 13

Medicine (9 works) · Opioid (6 works) · Opioid Use Disorder Treatment (6 works) · Internal Medicine (5 works) · Psychiatry (4 works) · Sociology (4 works) · Anesthesia (3 works) · Demography (3 works) · Drug (3 works) · Emergency Medicine (3 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae